Literature DB >> 8993211

Current pharmacologic treatment of multiple sclerosis symptoms.

P B Andersson1, D E Goodkin.   

Abstract

About 350,000 persons in the United States have multiple sclerosis, and primary care physicians are often called on to provide symptomatic therapy for these patients. We review our current pharmacologic approach to the management of multiple sclerosis exacerbations and the symptoms of spasticity, fatigue, bladder and bowel involvement, neurobehavioral complaints, pain syndromes, dystonic spasms, and tremor and ataxia.

Entities:  

Mesh：

Year:  1996        PMID： 8993211      PMCID： PMC1303858     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


  38 in total

1.  Intravenous methylprednisolone for multiple sclerosis in relapse.

Authors:  M P Barnes; D E Bateman; P G Cleland; D J Dick; T J Walls; P K Newman; M Saunders; P J Tilley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-02       Impact factor: 10.154

2.  The effect of oral corticosteroid dosage on CT enhancing multiple sclerosis plaques.

Authors:  R A Troiano; M P Hafstein; G Zito; M I Ruderman; P C Dowling; S D Cook
Journal:  J Neurol Sci       Date:  1985-08       Impact factor: 3.181

Review 3.  Drug therapy: spasticity (second of two parts).

Authors:  R R Young; P J Delwaide
Journal:  N Engl J Med       Date:  1981-01-08       Impact factor: 91.245

4.  Treatment of paroxysmal disorders in multiple sclerosis with carbamazepine (Tegretol).

Authors:  M L Espir; P Millac
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-08       Impact factor: 10.154

5.  Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up.

Authors:  G H Fromm; C F Terrence; A S Chattha
Journal:  Ann Neurol       Date:  1984-03       Impact factor: 10.422

6.  Colonic dysfunction in multiple sclerosis.

Authors:  M E Glick; H Meshkinpour; S Haldeman; N N Bhatia; W E Bradley
Journal:  Gastroenterology       Date:  1982-11       Impact factor: 22.682

7.  "Bolus" methylprednisolone versus ACTH in the treatment of multiple sclerosis.

Authors:  G Abbruzzese; C Gandolfo; C Loeb
Journal:  Ital J Neurol Sci       Date:  1983-06

8.  Treatment of pathologic laughing and weeping with amitriptyline.

Authors:  R B Schiffer; R M Herndon; R A Rudick
Journal:  N Engl J Med       Date:  1985-06-06       Impact factor: 91.245

9.  Depression and multiple sclerosis.

Authors:  A D Sadovnick; R A Remick; J Allen; E Swartz; I M Yee; K Eisen; R Farquhar; S A Hashimoto; J Hooge; L F Kastrukoff; W Morrison; J Nelson; J Oger; D W Paty
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

10.  Pain in multiple sclerosis.

Authors:  D B Clifford; J L Trotter
Journal:  Arch Neurol       Date:  1984-12
View more
  1 in total

1.  Advances in the treatment of multiple sclerosis.

Authors:  L B Krupp
Journal:  West J Med       Date:  1996-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.